Average Co-Inventor Count = 3.93
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (24 from 3,681 patents)
2. Bristol-myers Company (6 from 637 patents)
3. Other (1 from 832,680 patents)
4. Bristol Meyers Squibb Company (1 from 41 patents)
5. Institute of Organic Chemistry and Biochemistry of the Academy of (1 from 22 patents)
6. Rega Stichting, V.z.w. (1 from 21 patents)
7. Westwood Pharmaceuticals, Inc. (1 from 19 patents)
8. Muzammil M. Mansuri (0 patent)
9. John C. Martin (0 patent)
10. Thomas W. Hudyma (0 patent)
34 patents:
1. 7547690 - Compounds for the treatment of Hepatitis C
2. 7541353 - Compounds for the treatment of hepatitis C
3. 7521441 - Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
4. 7485633 - Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
5. 7473688 - Indolobenzazepine HCV NS5B inhibitors
6. 7456165 - HCV NS5B inhibitors
7. 7399758 - Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
8. 7348425 - Inhibitors of HCV replication
9. 7153848 - Inhibitors of HCV replication
10. 7022667 - O-derivatized nocathiacin derivatives
11. 6803374 - Compounds useful for treating hepatitis C virus
12. 6620799 - Water soluble prodrugs of azole compounds
13. 6620934 - Water soluble prodrugs of azole compounds
14. 6486159 - Water soluble prodrugs of azole compounds
15. 6458961 - Water soluble prodrugs of azole compounds